Drug · DIN 02379473
HYPERHEP B S/D
ALSO KNOWN AS HEPATITIS B IMMUNE GLOBULIN HUMAN. 1ML SYRINGE
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since July 16, 2024.
- Drug Identification Number (DIN)
- 02379473
- Company (DIN owner)
- Grifols Therapeutics LlcClayton, North Carolina, United States
- Schedule
- Schedule D
- Dosage form
- Solution
- Route
- Intramuscular
- Therapeutic class (ATC)
- Hepatitis B immunoglobulin J06BB04
- Class
- Human
- Record last updated
- June 18, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| HEPATITIS B IMMUNOGLOBULIN (HUMAN) | 220 UNIT | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- February 2, 2012: NOC 12991New Drug Submission (NDS) · Manufacturer name change
Other DINs named HYPERHEP B S/D
- DIN 02230738 · Cancelled Post Market
- DIN 02379465 · Cancelled Post Market